Table 2. Cox regression analysis for the progression-free survival of patients with astrocytic Tumors.
Variable | Univariate Cox Model | Multivariate Cox Model | ||||
---|---|---|---|---|---|---|
HR | 95%CI | p value | HR | 95%CI | p value | |
COX model of Classification, IDH, ATRX and Ki-67 | ||||||
Age ≤ 42 vs.>42 | 1.366 | 0.944-1.976 | 0.098 | |||
Male vs. Female | 0.924 | 0.635-1.346 | 0.682 | |||
IDH1-R132H positive vs. negative | 0.432 | 0.288-0.648 | 4.97E-05 | 0.218 | 0.067-0.71 | 0.012 |
ATRX loss vs. expression |
0.586 | 0.404-0.851 | 5.00E-03 | 0.941 | 0.559-1.585 | 0.82 |
Ki-67 expression low vs. high |
1.787 | 1.231-2.596 | 0.002 | 2,738 | 1.139-6.581 | 0.024 |
Classification | 1.672 | 1.316-2.126 | 2.63E-05 | 0.5 | 0.188-1.330 | 0.165 |
COX model of Classification and Grade | ||||||
Classification | 1.672 | 1.316-2.126 | 2.63E-05 | 1.512 | 1.062-2.153 | 0.022 |
WHO grade II/III vs. IV | 1.449 | 1.187-1.770 | 2.70E-04 | 1.121 | 0.835-1.504 | 0.447 |